SKShivanand Kattimani

Shivanand Kattimani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shivanand Kattimani has a total of 102 co-authors. Here are the top co-authors by number of shared publications:

  • Balaji Bharadwaj

    Dept. of Psychiatry, JIPMER, Dhanvantari Nagar, Pondicherry, India

    5 shared publications
  • Siddharth Sarkar

    National Drug Dependence Treatment Centre, All India Institute Of Medical Sciences, New Delhi, India

    5 shared publications
  • Karthick Subramanian

    Department of Psychiatry, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth (Deemed to be University), Puducherry, India

    4 shared publications
  • Padmavathi Nagarajan

    Department of Psychiatric Nursing, College of Nursing, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India

    4 shared publications
  • Arunkumar Kumaran

    Department of Psychiatry, Jawaharlal Institute of Postgraduate, Medical Education & Research, Puducherry 605 006, India

    2 shared publications
  • Nivedhitha Selvakumar

    Dept of Psychiatry, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India

    2 shared publications

Latest Publications

  • Open Access

    Mania in a Child with Scorpion Bite: Revisiting Catecholaminergic-cholinergic Theory of Mania

    by Farhan Koolimadu, Ragul Ganesh, Aakriti Jha, Venkatesh Chandrasekaran, Shivanand Kattimani

    Mania due to physical illness or drugs is conceptualized as secondary mania. Catecholaminergic-cholinergic imbalance theory is described for mania. A patient with scorpion envenomation treated with atropine represents such an imbalance. Reported here is a patient who developed manic symptoms in such a setting. The patient is a 14-year-old male child with a history of scorpion bite, presenting with cholinergic symptoms and respiratory failure. He was diagnosed with organophosphate poisoning (OP) as a history of scorpion bite was not available at presentation. He received atropine as per the OP protocol and, by Day 4, developed manic symptoms. He had no symptoms suggestive of delirium or anticholinergic toxicity except for mild tachycardia. He was treated with Olanzapine 5 mg, reaching remission by 1 week. The catecholaminergic-cholinergic theory posits mania to be a state of Catecholaminergic excess, mainly with a cholinergic-deficient state also contributing. This case clearly depicts such a state where envenomation induced a catecholaminergic excess state while atropinization would have induced a cholinergic-deficient state. This case re-emphasizes the Catecholaminergic-cholinergic imbalance theory of mania and calls for caution while treating scorpion envenomation with atropine.

  • Deprescribing fall risk-increasing drugs in older adults: implementation challenges and a conceptual framework from the DeFRID trial and global evidence

    by Madhavi Eerike, Sakthivadivel Varatharajan, Priyadharsini Rajendran, Paul Mathai, Veena Nayak, Vijaya Kumar Karra, Gomathi Ramaswamy, Rekha Priyadarshini, Gerard Marshall Raj, Venugopalan Gunasekaran, et al.

    Background: Deprescribing fall risk-increasing drugs (FRIDs) is essential for reducing polypharmacy and falls in older adults, yet randomized controlled trials (RCTs) face unique implementation challenges. The DeFRID study is an ongoing multi-center RCT evaluating an Assess, Review, Minimize, Optimize, and Reassess-based deprescribing intervention versus usual care in adults aged ≥60 years prescribed FRIDs. The objectives of this review are threefold: (1) to describe practical challenges encountered during a multi-center deprescribing RCT in India; (2) to propose a conceptual framework for categorizing these barriers; and (3) to contextualize DeFRID’s experience within the broader deprescribing research landscape. Methods: We conducted a narrative review with systematic scoping elements, synthesizing global RCT evidence from PubMed, OpenAlex, and Google Scholar (inception-December 2025) with DeFRID process evaluation data. DeFRID barriers and facilitators were identified via mixed-methods (clinician KAP questionnaire and qualitative interviews), team meetings, retention logs, and Phase II RCT implementation data, thematically categorized, and then compared with global RCT challenges. Results: DeFRID implementation revealed four challenge categories: ethical-clinical difficulties establishing equipoise for FRID withdrawal; operational barriers to recruitment and retention; methodological complexities in fall outcome ascertainment; and context-specific constraints unique to the Indian low- and middle-income countries setting—limited deprescribing guidelines, polypharmacy normalization, fragmented care coordination, and hierarchical decision-making. Global RCTs revealed substantial implementation challenges: low clinician adherence, short follow-up periods, restrictive eligibility excluding frail or cognitively impaired older adults, and resource-intensive interventions limiting scalability. Conclusions: Deprescribing FRIDs in older adults is impeded by ethical, operational, methodological, and provider-patient challenges, necessitating multilevel strategies integrating training, shared decision-making, context-specific guidelines, and stakeholder engagement for scalable implementation. Clinical trial registration number: The DeFRID trial is registered with the Clinical Trials Registry of India (CTRI/2023/12/060516) [https://ctri.nic.in/Clinicaltrials/pmaindet2.php?EncHid=ODg1NjM=&Enc=&userName=].

  • Open Access

    Therapeutic Interventions Targeted at Problematic Use of Digital Technology: Systematic Review and Meta-Analysis of Evidence

    by Yatan Pal Singh Balhara, Oshmita Bhattacharjee, Riya Kaur Bhatia, Rajkumar Sanahan, Ragul Ganesh, Siddharth Sarkar, Rajeev Ranjan, Shivanand Kattimani, Centre for Advanced Research on Addictive Behaviors (CAR-AB)

    Background: Problematic use of digital technology has increased across the world. Despite growing research, evidence on treatment effectiveness across digital behaviors remains fragmented. Objective: This study aimed to systematically evaluate and compare the effectiveness of therapeutic interventions targeted at problematic use of digital technology across various behavioral domains. Methods: A systematic review and meta-analysis was conducted in accordance with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 guidelines (PROSPERO: CRD420251052442). Electronic searches of PubMed, Scopus, and Embase (up to April 2025) were conducted. It identified 125 eligible studies, including 73 randomized controlled trials (RCTs), 32 non-RCTs, 14 pre-post studies, and 6 pilot studies. The interventions that were assessed in these studies included psychological therapies, digital or web-based programs, exercise-based interventions, pharmacological treatments, neuromodulation, parent-focused programs, virtual reality–based interventions, educational programs, and multicomponent approaches. Random-effects meta-analyses using standardized mean differences (SMDs) were performed. Results: For problematic internet use, psychological treatments showed a strong effect (effect size=−2.68; P <.001). Digital interventions also showed significant benefit (effect size=−1.16; P <.001). For smartphone addiction, psychological treatments (effect size=−1.49; P <.001) and exercise-based programs (effect size=−3.07; P =.001) showed significant improvement. For gaming disorder, psychological treatments showed improvement (effect size=−1.01; P =.02), but results were mixed. There were limited studies to calculate pooled results for social media addiction, pornography use, gambling, screen time, and over-the-top content watching. No treatment studies were found for problematic over-the-top content watching. High heterogeneity and evidence of small-study effects were observed in several studies. Conclusions: Overall, structured psychological therapies showed the most consistent benefit. These findings support structured interventions that aim for control of use and reduce cues linked to high use. Evidence remains limited for several emerging digital behaviors. More high-quality studies are needed in clinical settings and for less-studied forms of digital addiction.


  • Too Complex, Too Unreliable: Gaps in the Quality of Online Health Information for Adults with ADHD

    by Susheel Kumar Edacherian Kallen, Leeladharan Manavalan, Shivanand Kattimani

  • Open Access

    AGAINST: Adult ADHD is a valid condition requiring “clinical attention”!

    by Shivanand Kattimani

    Attention deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder with onset in childhood. DSM-5 requires several symptoms to be present before age 12. A controversial idea in recent years has been “adult-onset ADHD.” However, evidence supporting this construct remains weak. Most reported cases rely on retrospective adult self-report, lack collateral childhood data, or fail to rule out mimicking conditions (e.g., anxiety, depression, sleep disorders, substance use, medical and neurological causes). Methodological limitations include recall bias, non-equivalent assessment tools across life stages, and insufficient exclusion of alternative explanations. Longitudinal cohorts suggest that most purported “adult-onset” cases had earlier subthreshold or atypical difficulties. The balance of current evidence indicates that “pure” adult-onset ADHD is, at best, rare, and more often reflects missed childhood ADHD or symptomatic overlaps with other conditions. This commentary summarizes methodological flaws, alternative explanations, and critical views that caution against acceptance of adult-onset ADHD as a distinct nosological entity.

  • Open Access

    Association Between Emotional–behavioral Problems of Children with ASD and Parental Perceived Stress During COVID-19 First-wave Lockdown

    by Shivanand Kattimani, Greeshma Krishnankutty, Arivazhagan Karunanithi, Venkatesh Chandrasekaran

    Background: The first-wave stay-at-home mandate (lockdown) during coronavirus disease 2019 (COVID-19) pandemic disrupted routines across various aspects of life. Children with autism spectrum disorder (ASD) were at high risk of experiencing emotional–behavioral problems due to lockdown. We aimed to assess emotional–behavioral changes in children with ASD during the first wave of COVID-19 lockdown and its association with perceived stress in the parents. Methods: This cross-sectional study involved contacting parents of children with ASD over the telephone. We assessed 101 parents’ perceived stress using the Perceived Stress Scale, coping ability with the Brief Resilient Coping Scale, and changes in emotional or behavioral problems with the Strengths and Difficulties Scale (parental report). The latter was evaluated considering two-time frames: six months before the lockdown and one month during the lockdown. The association between perceived stress scores, changes in emotional–behavioral problems, child gender, and family type was tested using the Wilcoxon signed-rank test. Results: Emotional problems in children with ASD significantly increased during the lockdown compared to the pre-lockdown period ( z = −1.983, P = .047). Most parents showed medium to high resilient type of coping as measured on brief resilient coping scale. However, parents’ perceived stress was not significantly related to these increased emotional problems, but however linked with type of family and religious involvement. Conclusions: Children with ASD exhibited significantly increased emotional problems during the first wave of the COVID-19 lockdown compared to the pre-COVID-19 period, which did not correlate with parents’ stress levels.

  • Open Access

    Child sexual abuse awareness among parents visiting pediatric outpatient hospital services in Southern India

    by Tabassum Parvin, Padmavathi Nagarajan, Shivanand Kattimani, Venkatesh Chandrasekaran, Rajeev Seth

    Background: Child sexual abuse can have a deleterious impact and is of growing concern globally. Its prevention requires better awareness among the public from different cultures. Objectives: The objective of this study was to measure the awareness level of parents using the Child Sexual Abuse Awareness Scale. Participants and Setting: The current survey was conducted among parents visiting a pediatric outpatient service at a large tertiary care hospital in southern India. Methods: We used a semi-structured data sheet to collect sociodemographic data and used the Child Sexual Abuse Awareness Scale to measure the awareness levels of parents (CSAASP) (Berkmen and Seçim, 2019). It is a reliable and validated 23-item scale with three factors (myths, teachings and action against abuse, and recognizing signs of abuse). We analyzed the association between the level of awareness regarding child sexual abuse among parents attending the outpatient department and their sociodemographic variables. Results: The mean age of the participants was 31.8 years (range: 19–52 years). Out of the 273 participants, we had equal representation from both genders. Sixty-three percent were from rural residential backgrounds. Scores on CSA awareness significantly associated with participants’ level of education (Kruskal–Wallis test and Chi-square [df] = 9.139 [3], P = 0.027) and location of residence (Mann–Whitney U -test, Z = −3.081, P = 0.002). We found a significant correlation between the level of CSA awareness and the age and monthly household income of the participants ( ρ = 0.124, P = 0.041; ρ = 0.214, P = 0.000). Conclusions: Survey participants (parents) had a better awareness of CSA. The level of CSA awareness among parents was significantly better in those with higher education and those hailing from urban residential locations.